We are live on ! Find out more
TCM

Tamarack Capital Management Portfolio holdings

AUM $840M
1-Year Est. Return 19.47%
This Fund
S&P 500
This Quarter Est. Return
+22.45%
1 Year Est. Return
+19.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$659M
AUM Growth
+$208M
Cap. Flow
+$120M
Cap. Flow %
18.19%
Top 10 Hldgs %
61.19%
Holding
42
New
12
Increased
12
Reduced
11
Closed
3

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$36.6M
2
BDX icon
Becton Dickinson
BDX
+$16.4M
3
MDRX
Veradigm Inc. Common Stock
MDRX
+$15.9M
4
DXCM icon
DexCom
DXCM
+$11.5M
5
PRGO icon
Perrigo
PRGO
+$10.9M

Top Sells

Rank Stock Value
1
CFN
CAREFUSION CORPORATION
CFN
+$24.2M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$19.4M
3
MDXG icon
MiMedx Group
MDXG
+$13.3M
4
ALKS icon
Alkermes
ALKS
+$7.64M
5
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 59.41%
2 Technology 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$123M 18.71%
600,000
+100,000
+20% +$20.1M
ELGX
2
DELISTED
Endologix Inc
ELGX
$60.5M 9.18%
396,000
+66,000
+20% +$8.24M
DGX icon
3
Quest Diagnostics
DGX
$25.1B
$38.9M 5.9%
+580,000
New +$36.6M
SPNC
4
DELISTED
Spectranetics Corp
SPNC
$35.4M 5.38%
1,025,000
-125,000
-11% -$3.9M
IWM icon
5
CALL
iShares Russell 2000 ETF
IWM
$80.9B
$29.9M 4.54%
+250,000
New +$28.6M
ITGR icon
6
Integer Holdings
ITGR
$3.35B
$25.6M 3.88%
569,343
+48,564
+9% +$2.12M
MDT icon
7
Medtronic
MDT
$107B
$23.5M 3.56%
325,000
-45,000
-12% -$3.13M
BDX icon
8
Becton Dickinson
BDX
$43.1B
$23M 3.48%
169,125
+128,125
+313% +$16.4M
TEVA icon
9
Teva Pharmaceuticals
TEVA
$35.9B
$22.1M 3.36%
385,000
+155,000
+67% +$8.64M
INGN icon
10
Inogen
INGN
$167M
$21.1M 3.21%
674,000
+413,383
+159% +$10M
NXTM
11
DELISTED
NxStage Medical Inc.
NXTM
$19.7M 2.99%
1,100,000
– –
DXCM icon
12
DexCom
DXCM
$27.6B
$18.7M 2.84%
1,360,000
+940,000
+224% +$11.5M
ALKS icon
13
Alkermes
ALKS
$8.82B
$17.6M 2.66%
300,000
-150,000
-33% -$7.64M
MDRX
14
DELISTED
Veradigm Inc. Common Stock
MDRX
$16M 2.42%
+1,250,000
New +$15.9M
PDCO
15
DELISTED
Patterson Companies, Inc.
PDCO
$14.4M 2.19%
300,000
-70,000
-19% -$3.15M
PFE icon
16
CALL
Pfizer
PFE
$140B
$14M 2.13%
474,300
+52,700
+13% +$1.51M
ATRC icon
17
AtriCure
ATRC
$1.77B
$13.7M 2.07%
685,000
-15,000
-2% -$257K
BIO icon
18
Bio-Rad Laboratories Class A
BIO
$8.42B
$12.7M 1.92%
105,000
+21,622
+26% +$2.49M
PM icon
19
PUT
Philip Morris
PM
$301B
$12.2M 1.85%
150,000
– –
PRGO icon
20
Perrigo
PRGO
$1.4B
$11.7M 1.77%
+70,000
New +$10.9M
SRGA
21
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$10.5M 1.59%
67,241
-6,092
-8% -$877K
CTRX
22
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$10.3M 1.57%
+200,000
New +$9.4M
MYGN icon
23
Myriad Genetics
MYGN
$530M
$10.2M 1.55%
+300,000
New +$10.6M
HNGR
24
DELISTED
Hanger Inc.
HNGR
$9.95M 1.51%
454,501
+254,501
+127% +$5.52M
LMNX
25
DELISTED
Luminex Corp
LMNX
$9.38M 1.42%
500,000
-50,000
-9% -$950K
1
2

Similar funds

RI
Relational Investors San Diego, California $840M AUM 0.57% 1-Year Est. Return
CWA
Constellation Wealth Advisors New York $903M AUM 2.38% 1-Year Est. Return
GHF
Good Harbor Financial Barrington, Illinois $916M AUM 5.96% 1-Year Est. Return
F
FutureAdvisor San Francisco, California $617M AUM 6.57% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
BMCMI
Bryn Mawr Capital Management Inc Bryn Mawr, Pennsylvania $577M AUM 6.5% 1-Year Est. Return
GACM
Green Arrow Capital Management New York $535M AUM 14.21% 1-Year Est. Return
AH
Achievement Holdings Chicago, Illinois $1.2B AUM 9.2% 1-Year Est. Return

Tamarack Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Tamarack Capital Management held 42 positions worth $659M, up 46% from $451M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Tamarack Capital Management deployed $120M of net new capital in Q4 2014, opening 12 new positions and adding to 12 existing holdings. Its largest new stake was Quest Diagnostics: 580,000 shares worth $38.9M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 56% a quarter earlier, followed by Technology.

On the sell side, the largest reduction was CAREFUSION CORPORATION, an estimated $24.2M trimmed.

  • Tamarack Capital Management's largest Q4 2014 buy was Quest Diagnostics: 580,000 shares worth $38.9M.
  • Tamarack Capital Management added most to Becton Dickinson in Q4 2014, an estimated $16.4M increase.
  • Tamarack Capital Management's biggest Q4 2014 reduction was CAREFUSION CORPORATION, cutting an estimated $24.2M.
  • Tamarack Capital Management fully exited AUXILIUM PHARAMCEUTICALS INC in Q4 2014, selling an estimated $19.4M.
  • Tamarack Capital Management's ten largest holdings make up 61% of its $659M portfolio in Q4 2014.
  • Tamarack Capital Management opened 12 new positions and closed 3 in Q4 2014.
  • Tamarack Capital Management's portfolio value rose 46% quarter-over-quarter to $659M.

Based on Tamarack Capital Management's 13F filing for Q4 2014, filed 11 Feb 2015.